What is the Santen Pharmaceutical Co., Ltd. stock price forecast?

Santen Pharmaceutical Co., Ltd. is currently trading at ¥1,902.5. View real-time AI analysis on Alpha Lenz.

What is Santen Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Santen Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Santen Pharmaceutical Co., Ltd.'s P/E ratio?

Santen Pharmaceutical Co., Ltd.'s P/E ratio is 18.3.

Santen Pharmaceutical Co., Ltd.

JPX · 4536

¥1,903-21(-1.09%)Market closed

Ask about Santen Pharmaceutical Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Santen Pharmaceutical Co., Ltd. trades at a P/E of 18.3 (fair value) with solid ROE of 12.2%.”

Ask for details →

Company Overview

Santen Pharmaceutical Co., Ltd. is a prominent pharmaceutical company focusing on ophthalmology. Established in 1890 and headquartered in Osaka, Japan, Santen specializes in the research, development, and manufacturing of innovative eye care products. The company's portfolio includes a wide range of treatments for a variety of ophthalmic conditions such as glaucoma, dry eye, and retinal diseases. Santen has a strong emphasis on R&D to deliver advanced therapies and improve the quality of life for patients worldwide. Alongside traditional pharmaceutical products, the company also explores new areas such as digital ophthalmic solutions and regenerative medicine. Santen Pharmaceutical Co., Ltd. serves a global market, maintaining a significant presence in Europe and Asia, with a growing influence in North America. Its commitment to eye health, alongside strategic partnerships and a robust pipeline, position the company as a leader in the ophthalmology sector, contributing significantly to advancements in the treatment of eye diseases.

CEOMr. Takeshi Ito

Websitehttps://www.santen.com/en

SectorHealthcare

IndustryDrug Manufacturers - General

Employees3,849

Company Statistics

FY 2025

Profile

¥663,368,340,198Market Cap

¥300,004,000,000Revenue

0.00Shares Out

3,849Employees

Margins

57.01%Gross

19.67%EBITDA

15.63%Operating

15.83%Pre-Tax

11.95%Net

Valuation

18.30P/E

2.32P/B

2.21EV/Sales

9.65EV/EBITDA

N/AP/FCF

Growth (CAGR)

4.06%Rev 3Yr

4.43%Rev 5Yr

9.32%Op Inc 3Yr

6.93%Op Inc 5Yr

9.66%Net Inc 3Yr

10.55%Net Inc 5Yr

Returns

8.49%ROA

12.24%ROE

11.88%ROIC

Financial Health

¥92,997,000,000Cash & Cash Equivalents

¥31,099,000,000Net Debt

43.51%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Santen Pharmaceutical Co., Ltd. trades at a P/E of 18.3 (fair value) with solid ROE of 12.2%.”

Ask for details →

Frequently Asked Questions

Santen Pharmaceutical Co., Ltd. (ticker: 4536) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - General). It has approximately 3,849 employees. Market cap is $663.4B.

The current price is 1,902.5 with a P/E ratio of 18.3x and P/B of 2.32x.

ROE is 12.24% and operating margin is 15.63%. Annual revenue is $300.0B.